The document discusses various prodrugs, their mechanisms, and applications, such as estermustine for prostate cancer and erythromycin for infections. It details the hydrolysis processes mediated by different types of enzymes and the significance of promoieties in enhancing pharmacokinetics. Specific examples illustrate the challenges faced by certain prodrugs, including their stability and absorption improvements.